Acta Veterinaria et Zootechnica Sinica ›› 2025, Vol. 56 ›› Issue (4): 1594-1607.doi: 10.11843/j.issn.0366-6964.2025.04.011

• Review • Previous Articles     Next Articles

Research Progress on Virulence Regulation and Antivirulence Drugs of Staphylococcus aureus

JI Xing(), LI Jun, WANG Ran, HE Tao*()   

  1. Institute of Agricultural Product Safety and Nutrition/Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
  • Received:2024-04-16 Online:2025-04-23 Published:2025-04-28
  • Contact: HE Tao E-mail:jixing@jaas.ac.cn;vethetao@163.com

Abstract:

Staphylococcus aureus (S. aureus) is an important zoonotic pathogen capable of causing various infectious diseases, posing a serious threat to human and animal health. It produces multiple virulence factors such as toxins, adhesion proteins, and immune evasion factors, and possesses a complex regulatory network for virulence. Due to issues like antibiotic resistance faced by traditional antibiotic treatments, the development of novel drugs aimed at reducing or eliminating the virulence of S. aureus has become a new direction in antimicrobial drug development. This article provides a comprehensive review of the latest advances in the regulation of S. aureus virulence and the development of antivirulence drugs, offering a reference and scientific basis for understanding the pathogenic mechanisms of S. aureus and further research on antivirulence drugs.

Key words: Staphylococcus aureus, virulence, regulatory mechanisms, antivirulence drugs

CLC Number: